Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
Biosimilar Lymphocyte Modulator Global Market Report 2024
... 3) Distribution Channel: Online Pharmacies; direct to consumerCovering: Pfizer Inc.; Biogen Inc.; Celltrion Inc.; Genentech Inc.; Novartis AG Biosimilar Lymphocyte Modulator Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Erythropoietin Drugs Market Forecasts to 2030 – Global Analysis By Type (Biosimilars and Biologics), Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa and Other Products), Distribution Channel, Application, End User and By Geography
... Erythropoietin Drugs Market is accounted for $10.7 billion in 2023 and is expected to reach $25.6 billion by 2030 growing at a CAGR of 13.2% during the forecast period. Erythropoietin drugs are a class of ... Read More
-
US Pharmaceutical Market Size and Forecast (2020 - 2030), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Vaccines, Biologics & Biosimilars, and Small Molecules)
... grow from US$ 846.72 billion in 2022 to US$ 1,285.79 billion by 2030, estimated to grow at a CAGR of 5.36% from 2022 to 2030. The US pharmaceutical market growth in the US pharmaceutical market ... Read More
-
Asia Pacific Next Generation Antibody Market, By Therapeutic Area (Oncology, Autoimmune/Inflammatory); By Technology (Antibody-Drug Conjugates (ADC's), Bispecific Antibodies, FC Engineered Antibodies, Antibody Fragments and Antibody-like Proteins, Biosimilar Antibody Products); By Country (China, India, Japan, South Korea, Indonesia, Vietnam, Malaysia, Rest of Asia Pacific), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... antibody research and development programs, advancements in biotechnology, and expanding healthcare infrastructure. BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Asia Pacific Next Generation Antibody Market size ... Read More
-
Insulin biosimilars Global Market Report 2024
... Retail Pharmacies; Online Pharmacies4) By End User: Hospitals; Ambulatory Surgical CentersCovering: Eli Lilly and Company; Boehringer Ingelheim GmbH; Merck & Co Inc.; Pfizer Inc.; Biocon Ltd. Insulin biosimilars Global Market Report 2024 from The Business ... Read More
-
Biobetters Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Biobetters Market has demonstrated robust growth from 2024 to 2031. This growth trajectory is set to continue, with an anticipated steady CAGR of 10% expected between 2024 and 2031. In 2024, the global Biobetters Market ... Read More
-
Global Insulin Biosimilars Market - 2023-2030
... period 2023-2030. Biosimilars are equivalent to a reference biologic drug and are developed after the patent on the concerned biologic drug has passed. Biosimilar insulin is a biological replica of an actual insulin and there ... Read More
-
Oncology Biosimilars Market by Application (Cancer Treatment Drugs, Supportive Care Drugs), End-User (Hospitals, Retail Pharmacies) - Global Forecast 2024-2030
... reach USD 5.48 billion in 2024, at a CAGR 18.11% to reach USD 14.91 billion by 2030. Global Oncology Biosimilars Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Oncology Biosimilars ... Read More
-
Bioprocess Technology Market by Product (Consumables & Accessories, Instruments), Application (Antibiotics, Biosimilar, Monoclonal Antibodies), End-User - Global Forecast 2024-2030
... reach USD 23.70 billion in 2024, at a CAGR 12.39% to reach USD 47.95 billion by 2030. Global Bioprocess Technology Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Bioprocess Technology ... Read More
-
Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Global Forecast 2024-2030
... at USD 9.88 billion in 2023 and expected to reach USD 10.59 billion in 2024, at a CAGR 7.44% to reach USD 16.35 billion by 2030. Global Biologics Contract Development & Manufacturing Organization MarketBiologics contract ... Read More
-
Bioprocess Analyzers Market by Type (Consumables & Accessories, Instruments), Application (Antibiotics, Biosimilars, Recombinant Proteins), End User - Global Forecast 2024-2030
... to reach USD 581.42 million in 2024, at a CAGR 11.54% to reach USD 1,121.04 million by 2030. Global Bioprocess Analyzers Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Bioprocess ... Read More
-
Biosimilars Market by Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Indication (Autoimmune Diseases, Blood Disorders, Chronic Diseases), Manufacturing - Global Forecast 2024-2030
... 2023 and expected to reach USD 49.91 billion in 2024, at a CAGR 23.31% to reach USD 176.48 billion by 2030. Global Biosimilars Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Protein Engineering Market by Type (Coagulation Factors, Colony-Stimulating Factors, Erythropoietins), Product & Service (Consumables, Instruments, Software & Services), Technology, End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 4.16 billion in 2024, at a CAGR 10.21% to reach USD 7.49 billion by 2030. Global Protein Engineering Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Erythropoietin Stimulating Agents Market by Type (Darbepoetin Alfa, Epoetin Alfa, Epoetin Beta), Application (Anemia, Antiretroviral Treatment, Cancer Chemotherapy) - Global Forecast 2024-2030
... 2023 and expected to reach USD 10.32 billion in 2024, at a CAGR 5.64% to reach USD 14.45 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Erythropoietin Stimulating ... Read More
-
Biosimilar Monoclonal Antibodies Market by Drug Class (Abciximab, Adalimumab, Bevacizumab), Application (Diagnostic, Protein Purification, Therapeutic) - Global Forecast 2024-2030
... to reach USD 9.47 billion in 2024, at a CAGR 23.19% to reach USD 33.14 billion by 2030. Global Biosimilar Monoclonal Antibodies Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
TNF Inhibitors Market by Product (Biosimilars, Cimzia, Enbrel), Application (Ankylosing Spondylitis, Crohn’s Disease, Hidradenitis Suppurativa) - Global Forecast 2024-2030
... reach USD 36.15 billion in 2024, at a CAGR 6.92% to reach USD 54.06 billion by 2030. Global TNF Inhibitors Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the TNF Inhibitors ... Read More
-
Biopharmaceuticals Contract Manufacturing Market by Product (Biologics, Biosimilar), Source (Mammalian, Microbial-Based Biologics or Non-Mammalian), Contract Type, Service, Scale of Operation, Therapeutic Applications - Global Forecast 2024-2030
... USD 37.49 billion in 2023 and expected to reach USD 43.43 billion in 2024, at a CAGR 16.34% to reach USD 108.17 billion by 2030. Global Biopharmaceuticals Contract Manufacturing Market FPNV Positioning Matrix The FPNV ... Read More
-
Global Markets for Generic Drugs
... report covers small molecule drugs and biosimilars. It includes market drivers and challenges in the generic drug industry. The competitive landscape includes generic drug sales of key competitors and their ranking in the market. It ... Read More
-
Global Biosimilars Market Research Report 2024(Status and Outlook)
... standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. Biosimilars are officially approved versions of original ""innovator"" products and can be manufactured when the original product's patent expires. Reference to the ... Read More
-
Global Adalimumab Monoclonal Antibody Biosimilar Market Research Report 2024(Status and Outlook)
... The Global Adalimumab Monoclonal Antibody Biosimilar Market Size was estimated at USD 473.99 million in 2023 and is projected to reach USD 960.91 million by 2029, exhibiting a CAGR of 12.50% during the forecast period. ... Read More
-
Biosimilars Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... of Biosimilars in the Healthcare Industry Drives Revenue • High Manufacturing Costs Pose Challenges for Market Growth The global biosimilars market is on a remarkable growth trajectory during forecast period. It is expected to reach ... Read More
-
2024 Global Forecast for Biosimilars Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in 2025 ... Read More
-
2024 Global Forecast for Bio-Pharma Logistics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in 2025 ... Read More
-
Thematic Intelligence - Biosimilars in oncology
... the products. The report includes the 8MM regulatory landscapes, their market potential, and their available and upcoming biosimilars. Additionally, the report includes the opportunities and challenges facing biosimilar uptake and a commercial assessment of the ... Read More
-
Human Insulin Drugs Market in Brazil 2024-2028
... report on the human insulin drugs market in Brazil provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
Research Assistance
